TIDES EUROPE 2026
Meet us at TIDES Europe 2026, Europe's leading conference for oligonucleotide, peptide and mRNA therapeutics. The event covers key development, analytical, manufacturing and CMC challenges from discovery to commercialisation.
If you are developing oligonucleotide- or peptide-based therapeutics, robust analytical characterisation is essential to support product development, quality assessment and regulatory submissions.
Connect with Axelle Vanderbeque, Jordan Cossu and Damien Mouvet. We will also present a scientific poster showcasing our expertise in this field.